{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:06:40Z","timestamp":1777529200057,"version":"3.51.4"},"reference-count":15,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JNS"],"published-print":{"date-parts":[[2008,2]]},"abstract":"<jats:sec>\n<jats:title>Object<\/jats:title>\n<jats:p>The aim of this paper was to determine prognostic factors for adult medulloblastoma treated with boost Gamma Knife surgery (GKS) following resection and craniospinal irradiation.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>The authors performed a retrospective analysis of 12 adult patients with histologically proven medulloblastoma or supratentorial primitive neuroectodermal tumor who between February 1991 and December 2004 underwent \u2265 1 sessions of GKS for posttreatment residual or recurrent tumors (6 tumors in each group). Before GKS, all patients had undergone a maximal feasible resection followed by craniospinal irradiation. Nine patients also received systemic chemotherapy. Stereotactic radiosurgery was applied to residual and recurrent posterior fossa tumor as well as to foci of intracranial medulloblastoma metastases. The median time interval from initial diagnosis and resection to the first GKS treatment was 24 months (range 2\u201337 months). The mean GKS-treated tumor volume was 9.4 cm<jats:sup>3<\/jats:sup> (range 0.5\u201339 cm<jats:sup>3<\/jats:sup>).<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Following adjunctive radiosurgery, 5 patients had no evidence of tumor on magnetic resonance (MR) imaging, 3 patients had stable tumor burden on MR imaging, and 4 patients had evidence of tumor progression locally with or without intracranial metastases. All patients with tumor progression died. Eight patients survive with a mean cumulative follow-up of 72.4 months (range 21\u2013 152 months). No acute radiation toxicity or delayed radiation necrosis was observed among any of the 12 patients. The majority of patients who achieved tumor eradication (80%) and tumor stabilization (67%) after GKS had residual tumor as the reason for their referral for GKS. The best outcomes were attained in patients with residual disease who were younger, had smaller tumor volumes, had no evidence of metastatic disease, and had received higher cumulative GKS doses.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Single or multiple GKS sessions were a well-tolerated, feasible, and effective adjunctive treatment for posterior fossa residual or recurrent medulloblastoma as well as intracranial metastatic medulloblastoma in adult patients.<\/jats:p><\/jats:sec>","DOI":"10.3171\/jns\/2008\/108\/2\/0204","type":"journal-article","created":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T15:30:04Z","timestamp":1201879804000},"page":"204-209","source":"Crossref","is-referenced-by-count":21,"title":["Boost Gamma Knife surgery during multimodality management of adult medulloblastoma"],"prefix":"10.3171","volume":"108","author":[{"given":"Anand V.","family":"Germanwala","sequence":"first","affiliation":[{"name":"Departments of Neurological Surgery and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey C.","family":"Mai","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, University of Washington Medical Center, Seattle, Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nestor D.","family":"Tomycz","sequence":"additional","affiliation":[{"name":"Departments of Neurological Surgery and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay","family":"Niranjan","sequence":"additional","affiliation":[{"name":"Departments of Neurological Surgery and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John C.","family":"Flickinger","sequence":"additional","affiliation":[{"name":"Radiation Oncology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Kondziolka","sequence":"additional","affiliation":[{"name":"Departments of Neurological Surgery and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Dade","family":"Lunsford","sequence":"additional","affiliation":[{"name":"Departments of Neurological Surgery and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1754","reference":[{"key":"b1-1080204","series-title":"Neurosurgery","first-page":"623","article-title":"Adult Medulloblastoma: Prognostic factors and patterns of relapse","volume":"47","author":"Chan","year":"2000"},{"key":"b2-1080204","series-title":"Cell Death Differ","first-page":"267","article-title":"Inactivation of p53 is associated with decreased levels of radiation-induced apoptosis in medulloblastoma cell lines","volume":"2","author":"Dee","year":"1995"},{"key":"b3-1080204","series-title":"Neuro Oncol","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/neuonc\/4.2.115","article-title":"MDM2 overexpression is associated with short survival in adults with medulloblastoma","volume":"4","author":"Giordana","year":"2002"},{"key":"b4-1080204","series-title":"Neuro Oncol","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1215\/15228517-3-1-29","article-title":"Adult medulloblastoma: multiagent chemotherapy","volume":"3","author":"Greenberg","year":"2001"},{"key":"b5-1080204","series-title":"J Neurol","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00415-005-0560-2","article-title":"Adult medulloblastoma: prognostic factors and response to therapy at diagnosis and at relapse","volume":"252","author":"Herrlinger","year":"2005"},{"key":"b6-1080204","series-title":"Clin Nucl Med","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/01.RLU.0000057620.80401.0D","article-title":"In-111 octreotide scintigraphy in adult medulloblastoma","volume":"28","author":"Hervas","year":"2003"},{"key":"b7-1080204","series-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0360-3016(01)01518-8","article-title":"Radiosurgery in the management of pediatric brain tumors","volume":"50","author":"Hodgson","year":"2001"},{"key":"b8-1080204","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1097\/00006123-199710000-00004","article-title":"Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms","volume":"41","author":"Kondziolka","year":"1997"},{"key":"b9-1080204","series-title":"Neuroradiology","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00234-003-1011-3","article-title":"MRI of medulloblastoma in adults","volume":"45","author":"Malheiros","year":"2003"},{"key":"b10-1080204","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"690","DOI":"10.3171\/jns.1994.81.5.0690","article-title":"Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy","volume":"81","author":"Packer","year":"1994"},{"key":"b11-1080204","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3171\/jns.1991.74.3.0433","article-title":"Improved survival with the use of adjuvant chemotherapy in the treatment of medulloblastoma","volume":"74","author":"Packer","year":"1991"},{"key":"b12-1080204","series-title":"Pediatr Neurosurg","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1159\/000120901","article-title":"Results of radiosurgery in the management of recurrent and residual medulloblastoma","volume":"22","author":"Patrice","year":"1995"},{"key":"b13-1080204","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1023\/A:1016357731363","article-title":"Are childhood and adult medulloblastomas different? A comparative study of clinicopathological features, proliferation index, and apoptotic index","volume":"59","author":"Sarkar","year":"2002"},{"key":"b14-1080204","series-title":"Eur J Cancer","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.ejca.2005.02.022","article-title":"Survival of adults treated for medulloblastoma using pediatric protocols","volume":"41","author":"Spreafico","year":"2005"},{"key":"b15-1080204","series-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S0360-3016(97)00022-9","article-title":"The use of stereotactic radiosurgical boost in the treatment of medulloblastomas","volume":"37","author":"Woo","year":"1997"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/108\/2\/article-p204.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/108\/2\/article-p204.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/108\/2\/article-p204.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T09:38:34Z","timestamp":1709977114000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/108\/2\/article-p204.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":15,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3171\/jns\/2008\/108\/2\/0204","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}